Scotland’s TC BioPharm joins bluebird to develop next-gen CAR-T – pharmaphorum
pharmaphorum |
Scotland's TC BioPharm joins bluebird to develop next-gen CAR–T
pharmaphorum US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR–T cells. As reported by pharmaphorum earlier this year, TC BioPharm has already won EU funding to develop its “off-the-shelf” chimeric antigen … |
